Indian Army Department of Military Affairs Medical Injectables Tender 2026 India
Bid Publish Date
09-Oct-2026, 6:09 pm
Bid End Date
19-Oct-2026, 7:00 pm
Progress
Tender Overview
The Indian Army, Department of Military Affairs, issues a medical injectables procurement tender in India for 9 distinct injectable items, listed as Inj Revici, Inj Adrenaline, Inj Dextrose FIFTY PERCENTAGE, Inj Phenylbutazone, Inj Ascorbic acid, Inj Ondansetron, Inj Vitamin AD3E, Inj Vitamin A concentrate, and Inj Frusemide. The BOQ comprises 9 items, with quantity and unit details not disclosed in the available data. Estimated value and EMD amount are not specified. A key bidder opportunity is the option clause allowing quantity variation up to 25% during contract execution. Delivery timelines are tied to the original delivery schedule with adjustments for extended periods. This tender targets medical supply vendors experienced in injectable pharmaceuticals for military use.
Technical Specifications & Requirements
- No explicit product specifications provided in the data.
- Item names align with standard hospital/institutional injectables: Inj Revici, Inj Adrenaline, Inj Dextrose 50%, Inj Phenylbutazone, Inj Ascorbic acid, Inj Ondansetron, Inj Vitamin AD3E, Inj Vitamin A concentrate, Inj Frusemide.
- No Standard numbers (IS/ISO) or packaging/traceability details listed.
- No delivery location, installation, or warranty details available.
- Buyer terms define quantity option and delivery-time computations but lack exact delivery windows or penalties in the data.
- The procurement appears to emphasize flexible ordering and adherence to the option clause during contract execution.
Terms & Eligibility
- EMD amount: not disclosed in tender data.
- Quantity variation: purchaser may increase/decrease up to 25% of bid/contract quantity.
- Extended delivery: additional time calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.
- Delivery period adjustments may apply during extended periods; bidders must comply with the option-term mechanics.
- No explicit payment terms, warranty, or penalty clauses provided in the data.
- 9-item BOQ indicates medical injectables for defense use; supplier must be prepared for military-grade procurement processes.
Key Specifications
-
Total items: 9 injectable products
-
Item names include: Inj Revici, Inj Adrenaline, Inj Dextrose 50%, Inj Phenylbutazone, Inj Ascorbic acid, Inj Ondansetron, Inj Vitamin AD3E, Inj Vitamin A concentrate, Inj Frusemide
-
Standards/certifications not specified in data; no explicit IS/ISO numbers provided
-
Delivery terms reference 25% quantity increase/decrease rights; not quantifying delivery deadlines
-
EMD/estimated value not disclosed; no packaging, storage, or shelf-life details provided
-
Warranty, penalties, or AMC requirements not stated in available information
Terms & Conditions
-
Flexible quantity clause allowing ±25% variation during and after order
-
Delivery period adjustments based on extended quantity with a minimum 30 days
-
No disclosed EMD amount, estimated value, or specific payment terms
Important Clauses
Option Clause
Purchaser may alter quantity by ±25% during contract; extended delivery period calculated as (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days
Delivery Schedule
Delivery commencement from last date of original delivery order; extended period may apply if option clause exercised
Penalties/Liquidated Damages
Not specified in data; no explicit LD terms provided
Bidder Eligibility
-
Experience in supplying injectable pharmaceuticals to government/military entities
-
Ability to meet military procurement compliance and documentation requirements
-
Demonstrated financial stability through audited statements
Tender Data
Bid Details
Quantity
345
Category
Inj Phenylbutazone
Bid Type
Single Packet Bid
Bid Validity
30 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
No
MII Purchase Preference
No
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Past Performance
10 %
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Inj Revici , Inj Adrenaline , Inj Dextrose FIFTY PERCENTAGE , Inj Phenylbutazone , Inj Ascorbic acid , Inj Ondansetron , Inj Vitamin AD3E , Inj Vitamin A concrentrate , Inj Frusemide
Delivery Details
Max Delivery Days
15
Delivery Locations
1
Delivery Cities
Leh
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Leh | Leh | - | - | 50 | 15 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-10007804.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
9 Items Sign in to view GEM price trends Sign in for GEM prices
Inj Revici
5 ml
Inj Adrenaline
1 ml
Inj Dextrose FIFTY PERCENTAGE
25 ml
Inj Phenylbutazone
30 ml
Inj Ascorbic acid
30 ml
Inj Ondansetron
4 ml
Inj Vitamin AD3E
10 ml
Inj Vitamin A concrentrate
2 ml
Inj Frusemide
10 ml
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj Revici | 5 ml | 50 | amp | bhatt26 | 10 | |
| 2 | Inj Adrenaline | 1 ml | 50 | amp | bhatt26 | 10 | |
| 3 | Inj Dextrose FIFTY PERCENTAGE | 25 ml | 100 | amp | bhatt26 | 10 | |
| 4 | Inj Phenylbutazone | 30 ml | 40 | vial | bhatt26 | 10 | |
| 5 | Inj Ascorbic acid | 30 ml | 50 | vial | bhatt26 | 10 | |
| 6 | Inj Ondansetron | 4 ml | 10 | amp | bhatt26 | 10 | |
| 7 | Inj Vitamin AD3E | 10 ml | 5 | vial | bhatt26 | 10 | |
| 8 | Inj Vitamin A concrentrate | 2 ml | 20 | amp | bhatt26 | 10 | |
| 9 | Inj Frusemide | 10 ml | 20 | vial | bhatt26 | 10 |
Categories
5
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for similar injectables supply
Financial statements (recent balance sheet/profit & loss)
EMD submission document (if required by organization)
Technical bid documents demonstrating compliance with injectable pharmaceutical standards
OEM authorization / if bidding as distributor
Any existing GMP/GLP/ISO certifications relevant to injectable drugs
Frequently Asked Questions
How to bid for the Indian Army injectables tender in India 2026?
Bidders must submit GST, PAN, experience certificates, and financials along with technical bid documents. Ensure compliance with military procurement norms. The tender permits a ±25% quantity variation and requires readiness for delivery within extended periods as per the option clause.
What documents are required for the medical injectables tender in India?
Required documents include GST certificate, PAN card, experience certificates for similar injectables, financial statements, EMD submission (if applicable), OEM authorizations, and technical compliance certificates demonstrating GMP/GLP standards for injectable pharmaceuticals.
What are the key items listed in the BOQ for this Army tender?
The BOQ comprises nine injectable items: Inj Revici, Inj Adrenaline, Inj Dextrose 50%, Inj Phenylbutazone, Inj Ascorbic acid, Inj Ondansetron, Inj Vitamin AD3E, Inj Vitamin A concentrate, and Inj Frusemide, with quantities not disclosed in the available data.
What is the delivery clause for quantity variation in this tender?
The purchaser may increase or decrease quantity up to 25% at the time of contract placement and during the currency of the contract with contracted rates; delivery time adjusts based on the extended period formula with a minimum 30 days.
Are there any explicit standards or certifications required for these injectables?
No explicit IS/ISO standards or certifications are stated in the available data; bidders should prepare to meet general pharmaceutical compliance and OEM authorization requirements as part of the technical bid.
When will payment terms be specified for this Army procurement?
The data provided does not include payment terms; bidders should seek clarification on payment milestones, such as submission of invoices after delivery and applicable government payment timelines during bid submission.
What is the minimum documentation needed to participate in the bid?
At minimum, include GST registration, PAN, experience certificates in injectable supplies, financial statements, OEM authorizations if applicable, and technical bid detailing compliance with injectable drug handling and storage.
What is the scope of warranty or service for these injectables?
Warranty/AMC details are not specified here; bidders should verify post-delivery service expectations and any warranty terms during bid clarification with the Indian Army procurement team.